Lunit

Lunit is a pioneering medical artificial intelligence (AI) company with a mission to conquer cancer through technology. By leveraging advanced deep learning, Lunit develops and provides innovative AI-powered solutions that significantly enhance the accuracy and efficiency of cancer diagnostics and treatment. The company's core focus is on two main areas: AI for cancer screening and AI for cancer treatment. Lunit's technology is trusted by healthcare professionals in over 3,800 sites across more than 50 countries, demonstrating its global impact and clinical validation.

The company's flagship products, Lunit INSIGHT and Lunit SCOPE, are at the forefront of this revolution. Lunit INSIGHT is a suite of AI solutions for medical image analysis, including mammography and chest x-rays, designed to help radiologists detect cancers at their earliest and most treatable stages. Lunit SCOPE is an AI biomarker platform that analyzes tissue slide images to predict a patient's response to immunotherapy, enabling oncologists to make more informed, personalized treatment decisions. Backed by over 200 published studies and having won numerous international AI challenges, Lunit is recognized as a world leader in medical AI technology.

How to use Lunit

Lunit's solutions are designed for seamless integration into existing clinical workflows, primarily for radiologists and oncologists. The typical process is as follows:

1. Integration: Lunit's software is integrated with a hospital's existing Picture Archiving and Communication System (PACS), electronic health record (EHR) systems, or digital pathology viewers.
2. Image Analysis: When a medical image (e.g., a mammogram, chest x-ray, or digital pathology slide) is captured, it is automatically or manually sent to the Lunit AI for analysis.
3. AI-Generated Results: The AI processes the image in seconds. For Lunit INSIGHT, it highlights suspicious lesions and provides a score indicating the probability of malignancy. For Lunit SCOPE, it quantifies biomarkers from tissue slides to predict treatment efficacy.
4. Clinical Review: The AI-generated insights are presented to the clinician (radiologist or oncologist) directly within their standard viewing software. This serves as a 'second reader,' providing decision support.
5. Final Diagnosis & Treatment Plan: The clinician reviews the AI's findings along with their own assessment to make a final diagnosis or formulate a personalized treatment plan, combining human expertise with AI precision.

Core Features of Lunit

• AI-Powered Cancer Screening (Lunit INSIGHT): Provides highly accurate AI detection for cancers from chest x-rays (Lunit INSIGHT CXR) and mammograms (Lunit INSIGHT MMG). It helps identify suspicious nodules and lesions that might be missed by the human eye.
• AI Biomarker for Immunotherapy (Lunit SCOPE): Analyzes tumor tissue to predict a patient's response to cancer immunotherapy. It helps identify patients most likely to benefit from specific treatments, advancing precision oncology.
• Seamless Workflow Integration: Designed to integrate smoothly with existing hospital IT infrastructure, including PACS and digital pathology systems, ensuring minimal disruption to clinical routines.
• Clinically Validated Performance: The technology's effectiveness is supported by extensive research, with over 200 studies and abstracts, and has outperformed competitors in global AI competitions like Camelyon and VisDA.
• Global Scalability: Deployed in thousands of medical institutions worldwide, proving its robustness and adaptability to diverse clinical environments.

Use Cases for Lunit

Radiology Departments: Hospitals and imaging centers use Lunit INSIGHT to improve the accuracy and efficiency of breast and lung cancer screening. It acts as a tireless second reader, helping reduce radiologist burnout and decrease false negative rates.

Oncology Centers: Oncologists utilize Lunit SCOPE to stratify patients for immunotherapy. By analyzing tissue biomarkers, it helps in selecting the most effective treatment path, avoiding unnecessary and ineffective therapies for non-responders.

Large-Scale Health Screenings: Governments and public health organizations deploy Lunit's AI for mass screening programs, such as the Hajj season in Saudi Arabia, to efficiently process a high volume of medical images and identify at-risk individuals quickly.

Pharmaceutical Research: Lunit's AI biomarker platform can be used in clinical trials to identify patient cohorts that are more likely to respond to a new drug, accelerating drug development and increasing the chances of trial success.

Advantages of Lunit

Lunit offers a distinct advantage by bridging the gap between cutting-edge AI and practical clinical application. Its key strengths include superior diagnostic accuracy, which leads to earlier cancer detection and improved patient survival rates. The AI-driven workflow enhances productivity, allowing clinicians to focus on more complex cases. By providing predictive insights for treatment, Lunit champions the move towards personalized medicine, ensuring patients receive the most effective care. The company's strong foundation in research and collaboration with global partners like Microsoft and Guardant Health solidifies its position as a trusted and innovative leader in the fight against cancer.

Pricing and Plans

Lunit's solutions are enterprise-level products tailored for hospitals, medical institutions, and research partners. Pricing is not publicly listed and is provided on a custom-quote basis. The cost depends on several factors, including the specific products required (e.g., Lunit INSIGHT, Lunit SCOPE), the volume of usage, the scale of the institution, and the complexity of integration. Interested parties are encouraged to contact the Lunit sales team directly for a detailed consultation and personalized pricing proposal.